Job Creation Roars Back, Labor Secretary Mart...

From big tech earnings to the Fed's decision to hold rates steady... Carl Quintanilla, Sara Eisen, and David Faber broke down what investors should know this hour - and what it means for the markets - with an all-star cast including Janus Henderson's Global Macro Investing head a ...  Show more

Cramer says he’s troubled by this tech giant despite incredible advertising growth. Become an Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks every day as they talk candidly about the market’s biggest headlines, analyst calls and holdings in the Chari ...  Show more

The Dow was down 942 points at its session lows in a September-style selloff to start the week and Jim Cramer is helping investors navigate the day’s volatility. Then, as pharmaceutical companies focus on COVID-19, Eli Lilly CEO Dave Ricks checks in to discuss the company's pr ...

Former FDA chief Dr. Scott Gottlieb hopes the rate of Covid-19 infections in New York will start to slow next week, but wildcards like Texas and Florida could push the nation’s death toll close to the President’s sobering new estimates. Eurasia Group’s Ian Bremmer explains whe ...

The market today had a mixed bag day, with the S&P 500 and the NASDAQ falling while the Dow Jones Industrial Average gained 80 points, and Jim Cramer is digging into factors impacting the market this week. First, Jim sits down with Conagra CEO Sean Connolly to discuss the driv ...

DB-Dec08,2021:With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstratin ...  Show more